Workflow
能源ETF广发(159945)
icon
Search documents
能源ETF广发(159945)开盘跌0.34%,重仓股中国神华跌0.36%,中国石油跌0.30%
Xin Lang Cai Jing· 2025-12-05 01:35
来源:新浪基金∞工作室 风险提示:市场有风险,投资需谨慎。本文为AI大模型自动发布,任何在本文出现的信息(包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等)均只作为参考,不构成个人投资建 议。 能源ETF广发(159945)业绩比较基准为中证全指能源指数,管理人为广发基金管理有限公司,基金经 理为姚曦,成立(2015-06-25)以来回报为19.05%,近一个月回报为-0.68%。 12月5日,能源ETF广发(159945)开盘跌0.34%,报1.187元。能源ETF广发(159945)重仓股方面,中 国神华开盘跌0.36%,中国石油跌0.30%,陕西煤业涨0.44%,中国石化涨0.00%,中国海油涨0.21%,杰 瑞股份涨0.46%,兖矿能源跌0.14%,广汇能源涨0.00%,中煤能源跌0.36%,山西焦煤涨0.30%。 ...
基建、周期全线爆发 全市场百余只ETF单日涨超2%
Zhong Zheng Wang· 2025-07-22 10:55
Group 1 - The A-share market continues its strong momentum, with the Shanghai Composite Index achieving a five-day winning streak and reaching a new high for the year, with a total trading volume of 1.93 trillion yuan, an increase of 200 billion yuan compared to the previous trading day [1] - A total of 902 ETFs in the market rose, accounting for 73.5% of the total, with significant performance in sectors such as old infrastructure, state-owned enterprises, and energy resources [1] - Notably, 106 ETFs saw a daily increase of over 2%, with the leading product, the Infrastructure 50 ETF (516970), surging by 5.56% and achieving a trading volume exceeding 1.1 billion yuan [1] Group 2 - The Engineering Machinery ETF (560280) followed closely with a daily increase of 4.9%, focusing on the demand for machinery equipment in the Yajiang project, and recorded a net purchase of 20 million shares in the previous trading day [1] - The Energy ETF from GF (159945) also benefited from the strong performance of the coal and electricity sectors, rising over 4.5% [1] - Other ETFs, including the Materials ETF (159944), Rare Metals ETF (159608), and Central Enterprise Innovation ETF (515600), also saw daily increases exceeding 2%, showcasing GF Fund's diversified and meticulous layout in the index business [2] Group 3 - The Hong Kong Innovation Drug ETF (513120) maintained high activity, with a daily trading volume surpassing 10.8 billion yuan, and its latest scale exceeding 14.5 billion yuan, leading the market in the pharmaceutical ETF category [2] - The net value of the Hong Kong Innovation Drug ETF has increased by 118.18% over the past year [2]